Introduction
In patients with diabetes mellitus, cardiovascular diseases represent the first cause of mortality partly related to the development of a specific myocardial dysfunction called diabetic cardiomyopathy. 1, 2 Several studies identified diastolic dysfunction as the earliest functional alteration in the course of diabetic cardiomyopathy. [3] [4] [5] However, our group recently showed that diastolic dysfunction 6 was not always the first myocardial alteration in type 2 diabetes mellitus patients (DM2) and was associated with other factors than diabetes, such as age, hypertension, and obesity.
repeated echocardiograms, 5, 13, 14 in order to identify the predictive factors for deterioration of diastolic function over time in DM2 patients. 15 This study aimed to analyse diastolic function on repeated echocardiography in order to (1) describe diastolic function changes over 3 years in a cohort of DM2 patients prospectively enrolled and free of overt heart disease and (2) identify parameters associated with diastolic function deterioration over time.
Methods

Study population and protocol
All consecutive patients with DM2 referred to the endocrinology department of Lyon University Hospital since 2006 were screened in order to be enrolled in this prospective cohort study (R2D2). The selection criteria were: age between 35 and 75 years and oral antidiabetic or insulin treatment. The non-selection criteria were: signs or history of heart disease; absence of sinus rhythm; history of cardiomyopathy; coronary artery disease; creatinine clearance <30 mL/min; glycated haemoglobin (HbA1C)>12%; and blood pressure (BP) at rest > 180/100 mmHg.
The selected patients were referred for echocardiographic evaluation and stress test if not performed within the month before inclusion. Patients were included only if they met the following criteria as previously described: 7, 16 LV ejection fraction (LVEF)>55%, absence of regional LV wall motion abnormalities; absence of significant valvular heart disease; absence of poor acoustic window; absence of silent ischaemia. Silent ischaemia was excluded by exercise test, stress echocardiography or myocardial perfusion scintigraphy within the month before inclusion. All patients underwent clinical data collection, physical examination, echocardiography and blood samples analysis performed on the same day at inclusion and at 3-year follow-up according to the institutional cardiometabolic cohort study. Diabetes was treated in accordance to standards of care. 17 The committee on human research has approved the study protocol. All subjects gave informed consent to participate.
Clinical data
Data on age, sex, diabetes duration, smoking, and medications were collected from an interviewer-administered questionnaire. A complete physical examination was performed, including height, weight, heart rate. Patients rested 5 min in supine position before having ECG recording and three automated BP measurements (Dynamap Pro 200, General Electric) spaced by 1 min each. Blood pressure was averaged on the two last measurements, and then echocardiography was immediately performed. Diabetic retinopathy (presence vs. absence) was assessed by dilated eye examination using a Topcon retinograph as recommended annually in diabetic patients. Presence of neuropathy was determined on interview and physical examination with calibrated monofilament.
Biochemical analysis
Blood samples were drawn from fasting patients for LDL and HDLcholesterol, triglycerides, HbA1C, brain natriuretic peptide (BNP), and creatininemia measurements. Glomerular filtration rate (GFR) was calculated using the Modification in Diet Renal Disease formula. Albuminuria was measured by immune nephelometry on a random urine sample.
Echocardiography
Resting transthoracic echocardiography was performed in the left lateral decubitus position using commercially available ultrasound systems (Vivid 7/9, General Electric). Images were stored for off-line analysis (EchoPac, GE Vingmed).
Left ventricular end-diastolic and end-systolic diameters and wall thicknesses were measured on M-mode parasternal long-axis views. 18, 19 Relative wall thickness was calculated as (2x posterior end-diastolic wall thickness)/LV end-diastolic diameter. Left ventricular mass was calculated using Devereux's formula and indexed to height powered to 2.7. 20, 21 The LVEF was measured using the Simpson's biplane method. 18, 19 Systolic velocity S' was assessed at the lateral site of the mitral annulus using pulsedwave tissue Doppler imaging.
Diastolic functional analysis and diastolic function classification
Transmitral inflow was recorded using pulsed wave Doppler in the apical 4-chamber view for measurements of early (E) and late (A) mitral inflow velocities, and deceleration time of the E-wave (DT). Isovolumic relaxation time was measured as the delay between the end of the ejection flow and the onset of the mitral inflow using pulse wave Doppler in an apical 5-chamber view. Early diastolic velocity was assessed at the septal (septal e') and lateral (lateral e') sites of the mitral annulus using pulsedwave tissue Doppler imaging. The average value of septal and lateral e' was used to calculate E/e' ratio. The maximal left atrial (LA) area was measured by planimetry on apical 4-chamber view and the LA volume using Simpson's rule. Diastolic function classification was performed using the EACVI/ASE recommendations. 6 Patients were assigned to one of the four following groups: normal diastolic function or grade 1, 2, or 3 diastolic dysfunction. The first step consisted to classify patients according to the septal and lateral e' and LA volume. Patients with at least two of the following parameters: septal e'> _8 cm/s, lateral e'> _10 cm/s and LA volume < _ 34 mL/m 2 constitued the group with normal diastolic function. For the remaining patients, the following classification was used: grade 1 when E/A < 0.8, DT > 200 ms, and E/e'< _8; grade 2 when E/A was between 0.8 and 2, DT between 160 and 200 ms, E/e' ratio between 8 and 13; and grade 3 when E/A > 2, DT < 160 ms, E/é > _ 13.
Statistics
For detailed statistical analysis, see Supplementary data online, Appendix. Continuous and normally distributed data are presented as mean ± standard deviation, and categorical variables as frequencies (percentages). Paired t-test and non-parametric tests were used to assess changes between baseline and 3-year follow-up as appropriate. Comparisons between groups of patients with stable diastolic function, diastolic function deterioration or improvement during follow-up were performed using one-way ANOVA.
Logistic regression analyses were performed to identify factors associated with diastolic function deterioration. Similar analyses were repeated in the subgroup of patients with normal diastolic function at baseline.
Linear regression analyses were performed to identify factors associated with E/e' ratio, e' lateral and e' septal changes during follow-up.
Analyses were performed using SPSS for windows version 19 .0 (SPSS Inc., Chicago, IL) and R (version 2.15.2). P-values were two-tailed with an accepted significance level of 0.05.
Results
Patient characteristics
Among the 335 enrolled patients, 9 were lost to follow-up, 6 patients were censored (major coronary events: n = 4, stroke: n = 1, incident
persistent atrial fibrillation: n = 1), and 10 patients presented discordant diastolic functional parameters precluding diastolic function classification at baseline and/or 3 years follow-up. Thus, 310 patients were analyzed in the present study.
Evolution of clinical data between baseline and 3 years is summarized in Table 1 . Body mass index increased, but BP and HbA1C remained stable. The use of insulin increased from 11 to 46%. The use of glitazones decreased and was associated with a shift to the use of gliptins and GLP-1 agonists. The use of diuretics, angiotensin-II receptor blockers or ACE-inhibitors and calcium blockers increased significantly.
At baseline, 171 patients (55%) were treated for hypertension. Diabetic retinopathy was present in 23% of the patients, neuropathy in 26% and increased albuminuria in 45% (37% with albuminuria between 20 and 200 mg/L and 8% with albuminuria > _ 200 mg/L). The prevalence of neuropathy and albuminuria remained stable during follow-up. An increase in retinopathy prevalence and a decrease in glomerular filtration rate was observed.
Evolution of diastolic parameters between baseline and 3 years follow-up
Evolution of echocardiographic data between baseline and 3 years is summarized in Table 2 . Significant changes were: an increase in LA dimensions; a decrease in E velocity, E/A ratio, and a decrease in lateral e' and mean e' velocity but no change in septal e' and E/e' ratio. Of note, LV dimensions and LV mass/height 2 . remained stable. LVEF slightly decreased during follow-up but remaining within the normal range.
Distribution of the study population according to diastolic function classification at baseline and 3 years is shown in Figure 1 . The percentage of patients with diastolic dysfunction increased from 49% to 67% at baseline and 3 years, respectively (P = 0.001).
Only 98 (32%) patients had a normal diastolic function both at baseline and 3 years and 101 (33%) patients were also stable at grade 1 or grade 2. Diastolic function deterioration occurred in 83 (27%) patients with 20% of the study population evolving from normal diastolic function at baseline to diastolic dysfunction grade 1 or 2 at follow-up. Diastolic function improved only in 28 (9%) patients, mainly from grade 2 to grade 1 (82%) but without normalization. Comparisons of baseline characteristics between patients with stable, deteriorated or improved diastolic function during follow-up are provided in, Supplementary data online, Table S1. None of the patients developed heart failure during follow-up. BNP levels were in the normal range at baseline and 3 years. BNP did not correlate with diastolic class at baseline (F = 2.6; P = 0.08). After 3 years, BNP was higher in grade 2 vs. grade 1 (21 (Figure 2) . Of note, the slight decrease in LVEF was similar in patients with stable and deteriorated diastolic function (-1.1 ± 7.1% and -2.2 ± 7.4% respectively, P = 0.33).
Factors associated with diastolic function deterioration over the 3-year follow-up
Multivariable analysis identified age and retinopathy as independent baseline parameters associated with diastolic function deterioration. Increase in systolic BP together with age and retinopathy were also associated with diastolic function deterioration ( Table 3) . Similar results were found in patients with normal diastolic function at baseline (see Supplementary data online, Table S2 ).
Independent predictors of E/e' increase over 3 years were: female gender, age, HbA1c, albuminuria, heart rate changes and LV mass changes (see Supplementary data online, Table S3 ). Lateral e' changes were associated with age, HbA1c and changes in systolic BP but septal e' changes were only associated with age (see Supplementary data online, Tables S4 and S5).
Discussion
In this prospective observational study of 310 DM2 patients without overt heart disease, diastolic function deterioration occurred in 27% of patients with only 32% patients having a normal diastolic function at both baseline and 3 years. This deterioration was independently associated with age, retinopathy, and increase in systolic BP during follow-up.
Diastolic function deterioration over time in DM2 patients
With conventional echocardiography and tissue Doppler imaging, the prevalence of diastolic dysfunction in DM2 patients is high, ranging from 23 to 75%.
3,4,7-11 Diastolic dysfunction is an early, but not specific alteration of the diabetic myocardium since age, BMI, and BP are also major determinants. 7 The value of a high E/e' ratio as a predictor for heart failure and mortality has been reported in a large cohort study 3 but few data are available on diastolic function evolution over time. 5, 13, 14, 22 In the ADVANCE substudy, 22 e' velocity decreased, and both E/e' ratio and LA volume increased during a 4-year follow-up in a large cohort of DM2 patients including a significant proportion of patients with a history of major macrovascular disease (33%) and myocardial infarction (16%). Moreover, these diastolic parameters worsened despite BP reduction and LV mass regression associated with perindopril-indapamide treatment suggesting a role for LV structural abnormalities such as myocardial interstitial fibrosis. The Hoorn Study restricted the evaluation of diastolic function changes to the LA volume index over 8 years and enrolled DM2 patients with history of cardiovascular disease (48%), among them 21% presented heart failure. 5 Deformation imaging is also able to detect significant subtle diastolic function worsening during only 2 year follow-up. 13 In comparison with those studies, we did not enrol the patient in case of overt or suspected heart disease. Additionally, patients with a positive stress test or uncontrolled hypertension were excluded. We aimed to avoid the confounding effects of co-morbidities such as coronary artery disease on the evolution of diastolic function. Despite 
this selection, only 32% of the patients had a normal diastolic function both at baseline and 3 years.
Based upon the EACVI/ASE recommendations 6 for diastolic function evaluation, 27% of the patients of our study worsened their diastolic function during the 3-year follow-up. This may be clinically relevant since both diastolic function grade and its changes over time are markers of outcome. 3 In a population-based cohort of 1402 subjects (10% diabetic patients), the prevalence of diastolic dysfunction increased from 23.8 to 39.2% (P < 0.001) after a follow-up of 4 ± 0.3 years. 23 It was associated with incident heart failure after adjustment for age, hypertension, diabetes, and coronary artery disease. Also in a large sample of patients with LVEF > _ 55%, any worsening of diastolic function was associated with all-cause mortality during a follow-up of 1.1 ± 0.4 year. 24 
Factors associated with diastolic function deterioration
In our study, several surrogate markers of microvascular complications were independently associated with diastolic function worsening. This relationship suggests that diabetic microvascular complications and diastolic function deterioration are sharing common pathophysiological mechanisms. Although our study did not explore the underlying pathophysiology of diastolic function worsening, we may rely on previous studies showing structural changes in the myocardium with increased interstitial fibrosis [25] [26] [27] and increased myocardial triglyceride accumulation. 28 Tissue involvement by a fibrotic process is a major pathophysiological determinant of the of diabetic retinopathy, neuropathy and nephropathy. 25, 29, 30 In diabetic patients, microvascular complications and cardiomyopathy are also associated with interstitial accumulation of advanced-glycated end products (AGES) including elastin, collagen and other connective tissue proteins, oxidative stress, subclinical inflammation and activation of the renin-angiotensin-aldosterone system. 1, 16, 31 Microvascular alterations have also been described in diabetic heart resulting in hypoperfusion of the myocardium leading to LV compliance and contractility impairment. 32 These common underlying mechanisms might explain that diabetic retinopathy was a predictive marker of diastolic function deterioration in our study. This hypothesis is also supported by a 2.5-fold higher risk of heart failure in DM2 patients with diabetic retinopathy as compared to DM2 patients without retinopathy in a large population-based study 33 and the association between increased albuminuria and heart failure in DM2 patients. 34 Contrarily to a recent general population, 35 we did not find any association between heart rate change and diastolic function deterioration during follow-up. Such a discrepancy may be explained by the shorter follow-up of our study and the frequent dysautonomia observed in diabetic patients. Blood pressure level is a major determinant of diastolic dysfunction in DM2 patients 7 and also in non-diabetic population. 35, 36 In our population, baseline BP was well controlled and was not associated with diastolic function deterioration. However, an increase of 10 mmHg in systolic BP during follow-up exposed the patients to a 30% risk increase of diastolic function deterioration. LV mass did not significantly increase in our study as opposed to the initial transversal analysis of the Framingham Heart Study reporting a modest increment of LV mass over a 10 years duration assumption (3.92 g/m in men and 5.15 g/m in women). 37 The lack of LV mass increase in our study may be related to the short duration of followup in a selected population of DM2 patients without severe obesity or hypertension, two other key contributors to the increase in LV mass over time. Since diastolic dysfunction progressed in the absence of LV mass change in our population, we may speculate on the role of other previously reported factors such as interstitial myocardial fibrosis, 27 myocardial steatosis, 38 impaired coronary microcirculation, 39 and systemic low grade inflammation. 40 Diastolic dysfunction is usually characterized by impaired LV relaxation (resulting in disturbed early diastolic filling), loss or reduction of restoring forces and early diastolic suction, and decreased LV chamber compliance. At the early stage, the disturbed LV filling may be compensated by greater left atrial active filling in patients maintaining sinus rhythm. However, obesity frequently associated with DM2 has been reported to increase myocardial interstitial fibrosis and to accelerate age-associated ventricular stiffening (e.g. decreased compliance). 41, 42 This might contribute to elevated LV filling pressure in order to maintain stroke volume and ultimately lead to heart failure. 43 As expected, age and gender were independent predictors of E/e' ratio changes. Moreover, HbA1c, albuminuria and changes in heart rate and LV mass during follow-up were also independent predictors of E/e' increase. Those findings are in agreement with a recent observation in the general population. 35 Diastolic function improved but was not normalized in 28 patients who were older and had a higher systolic BP at baseline. Such an improvement is likely related to a better control of BP thanks to a more intensive treatment since these patients presented a decrease in systolic BP of 11 mmHg during follow up. At the opposite, the group with deterioration of diastolic function presented an increase in BP of 6 mmHg while BP remained unchanged (-1 mmHg) in the group without change in diastolic grade.
Clinical implications
In the context of diabetic cardiomyopathy, our study highlights the silent deterioration of diastolic function in more than one quarter of the patients while both LV geometry and LVEF were preserved. Diabetes affects 6 to 10% of the population worldwide and highly exposes to heart failure, even in the absence of coronary artery disease or hypertensive cardiomyopathy. Therefore, strategies to detect and prevent heart failure are needed. As abnormal LV filling pattern was associated with cardiovascular mortality in all-cause cardiomyopathy and diastolic dysfunction portends poor prognosis in DM2 patients, 3, 44 the presence of altered diastolic function might justify a careful follow-up to identify the patients at risk of heart failure, especially in case of microvascular complications.
Limitations
Ten subjects were not classified because of discordant parameters.
Since non-invasive diastolic function evaluation requires a multiparameter approach, 6 a small number of cases with discordant parameters is inevitable. 23 Impact of diastolic function deterioration on clinical events was not evaluated. However, the aim of our study was to determine predictive factors of subclinical diastolic function deterioration. In this perspective, we chose to censor patients with clinical events.
Coronary microcirculation was not assessed in our study. However, we paid attention to exclude myocardial ischaemia by functional test. The exclusion of myocardial ischaemia by a negative stress test was performed at inclusion but not repeated at 3 years follow-up. Therefore, the development of silent ischaemia might have contributed to the progressive deterioration of diastolic function over time.
Diastolic stress test might have been relevant for unmasking diastolic function at exercise. 45, 46 However, the data on the prognostic value of diastolic stress test are sparse, 47 especially as compared to the data evaluating the prognostic value of diastolic function at rest. 24 In conclusion, diastolic function deteriorates over time in a significant proportion of patients with type 2 diabetes mellitus. Age, retinopathy, and increase in blood pressure over time are associated with an increased risk of diastolic function deterioration in DM2 patients. Therefore, the presence of these co-factors might help to identify patients at risk to develop diastolic dysfunction and heart failure in this population.
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